Reductively dissociable biomimetic nanoparticles for control of integrin-coupled inflammatory signaling to retard atherogenesis.
Reductively dissociable biomimetic nanoparticles served as high-performance integrin activators to suppress downstream inflammatory signaling and plaque formation.